KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $6.02 $13.63 Friday, 26th Apr 2024 VERV stock ended at $6.16. This is 0.96% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.47% from a day low at $6.02 to a day high of $6.41.
90 days $6.02 $19.34
52 weeks $6.02 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Sep 24, 2021 $50.63 $51.88 $46.51 $47.93 496 218
Sep 23, 2021 $49.01 $53.39 $47.24 $51.99 658 001
Sep 22, 2021 $50.70 $51.61 $46.81 $47.02 431 076
Sep 21, 2021 $53.60 $56.05 $49.14 $49.87 748 469
Sep 20, 2021 $58.44 $59.80 $51.13 $51.78 736 630
Sep 17, 2021 $69.98 $71.04 $59.61 $59.88 2 898 642
Sep 16, 2021 $65.64 $69.91 $64.83 $69.87 513 075
Sep 15, 2021 $62.31 $64.90 $61.01 $64.52 513 109
Sep 14, 2021 $62.80 $64.52 $58.19 $62.12 436 624
Sep 13, 2021 $74.12 $76.07 $62.15 $62.62 471 097
Sep 10, 2021 $73.44 $75.55 $73.33 $73.99 295 419
Sep 09, 2021 $70.30 $74.22 $69.99 $73.26 372 306
Sep 08, 2021 $70.87 $71.87 $66.16 $70.07 391 732
Sep 07, 2021 $72.67 $78.00 $67.26 $70.46 461 080
Sep 03, 2021 $71.44 $72.50 $69.25 $71.39 343 409
Sep 02, 2021 $70.47 $72.79 $70.00 $71.46 236 195
Sep 01, 2021 $70.35 $73.52 $69.20 $70.70 180 734
Aug 31, 2021 $68.40 $70.35 $67.09 $69.96 194 471
Aug 30, 2021 $70.78 $74.44 $66.58 $68.25 232 289
Aug 27, 2021 $66.62 $70.96 $63.97 $70.33 256 911
Aug 26, 2021 $64.58 $71.00 $64.47 $65.81 293 597
Aug 25, 2021 $62.80 $65.92 $61.59 $64.94 213 212
Aug 24, 2021 $65.18 $65.45 $63.06 $63.44 255 212
Aug 23, 2021 $64.15 $66.27 $62.85 $65.05 548 502
Aug 20, 2021 $63.83 $65.35 $62.32 $63.31 260 789
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT